- Home
- IRWD vs CLBK Comparison
IRWD vs CLBK Comparison
Compare IRWD & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- CLBK
- Stock Information
- Founded
- IRWD 1998
- CLBK 1927
- Country
- IRWD United States
- CLBK United States
- Employees
- IRWD N/A
- CLBK N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- CLBK Savings Institutions
- Sector
- IRWD Health Care
- CLBK Finance
- Exchange
- IRWD Nasdaq
- CLBK Nasdaq
- Market Cap
- IRWD 150.9M
- CLBK N/A
- IPO Year
- IRWD 2010
- CLBK N/A
- Fundamental
- Price
- IRWD $0.70
- CLBK $15.35
- Analyst Decision
- IRWD Buy
- CLBK Hold
- Analyst Count
- IRWD 5
- CLBK 1
- Target Price
- IRWD $4.94
- CLBK $16.00
- AVG Volume (30 Days)
- IRWD 4.2M
- CLBK 153.5K
- Earning Date
- IRWD 05-07-2025
- CLBK 04-30-2025
- Dividend Yield
- IRWD N/A
- CLBK N/A
- EPS Growth
- IRWD N/A
- CLBK N/A
- EPS
- IRWD N/A
- CLBK N/A
- Revenue
- IRWD $317,676,000.00
- CLBK $176,914,000.00
- Revenue This Year
- IRWD N/A
- CLBK $30.97
- Revenue Next Year
- IRWD N/A
- CLBK $12.37
- P/E Ratio
- IRWD N/A
- CLBK N/A
- Revenue Growth
- IRWD N/A
- CLBK N/A
- 52 Week Low
- IRWD $0.59
- CLBK $12.64
- 52 Week High
- IRWD $8.23
- CLBK $19.28
- Technical
- Relative Strength Index (RSI)
- IRWD 29.40
- CLBK 63.78
- Support Level
- IRWD $0.88
- CLBK $13.36
- Resistance Level
- IRWD $0.98
- CLBK $15.40
- Average True Range (ATR)
- IRWD 0.10
- CLBK 0.47
- MACD
- IRWD 0.02
- CLBK 0.26
- Stochastic Oscillator
- IRWD 11.74
- CLBK 91.88
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.